Archives for April 6, 2009

← 2009

Pfizer awarded for human rights in research

By Phil Taylor

Pfizer has become the first drugmaker to win accreditation for protecting the human rights of subjects enrolled into early-stage clinical trials under a scheme operated by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

Pharma outsourcing: people on the move

By Phil Taylor

Outsourcing-Pharma.com presents its periodic round-up of executive appointments in the contract services sector and pharmaceutical industry.

Cash strapped MDRNA sells CMO unit to Par

By Gareth Macdonald

MDRNA is selling its manufacturing business to US generics firm Par Pharmaceuticals in a bid to boost its coffers and complete its transformation into a purely RNAi focused organisation.

Time of rapid change in fine chemicals supply, says SAFC

By Gareth Macdonald

Tom Beil, SAFC’s VP of Quality and Regulatory affairs, whose talk on fine chemicals supply was a highlight of last month's DCAT week, spoke with in-PharmaTechnologist about the benefits and risks of working with global suppliers.

Beckman Coulter buys Cogenics for $17m

Clinical Data is to sell Cogenics division, which provides services including sequencing and gene expression, to Beckman Coulter’s Agencourt Biosciences' business for $17m.

Researchers shed light on MRSA treatment

By Nick Taylor

MRSA could be treated through a combination of an antimicrobial drug, a peptide and light, according to researchers who have hailed the treatment as a “magic bullet”.